Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share By
Anti-Ige Monoclonal Antibodies As Potential Treatment in Covid-19 Publisher Pubmed



Farmani AR1, 2, 3 ; Mahdavinezhad F4 ; Moslemi R5 ; Mehrabi Z6 ; Noori A1 ; Kouhestani M1 ; Noroozi Z7 ; Ai J1 ; Rezaei N8, 9, 10
Authors

Source: Immunopharmacology and Immunotoxicology Published:2021


Abstract

Coronavirus disease 2019 (COVID-19) is associated with irreversible effects on vital organs, especially the respiratory and cardiac systems. While the immune system plays a key role in the survival of patients to viral infections, in COVID-19, there is a hyperinflammatory immune response evoked by all the immune cells, such as neutrophils, monocytes, and includes release of various cytokines, resulting in an exaggerated immune response, named cytokine storm. This severe, dysregulated immune response causes multi-organ damage, which eventually leads to high mortality. One of the most important components of hypersensitivity is immunoglobulin E (IgE), which plays a major role in susceptibility to respiratory infections and can lead to the activation of mast cells. There is also a negative association between IgE and IFN-α, which can reduce Toll-like receptor (TLR) nine receptor expression and TLR-7 signaling to disrupt IFN production. Moreover, anti-IgE drugs such as omalizumab reduces the severity and duration of COVID-19. In addition to its anti-IgE effect, omalizumab inhibits inflammatory cells such as neutrophils. Hence, blockade of IgE may have clinical utility as an immunotherapy for COVID-19. © 2021 Informa UK Limited, trading as Taylor & Francis Group.
Other Related Docs
5. Cytokines and Covid-19: Friends or Foes?, Human Vaccines and Immunotherapeutics (2020)
8. Introduction on Coronavirus Disease (Covid-19) Pandemic: The Global Challenge, Advances in Experimental Medicine and Biology (2021)
10. Health Care Policies and Covid-19 Prevalence: Is There Any Association?, International Journal of Health Services (2022)
11. Geriatrics and Covid-19, Advances in Experimental Medicine and Biology (2021)
14. Monoclonal Antibody As a Potential Anti-Covid-19, Biomedicine and Pharmacotherapy (2020)
15. Coronavirus: Pure Infectious Disease or Genetic Predisposition, Advances in Experimental Medicine and Biology (2021)
18. A Systematic Review of Pregnant Women With Covid-19 and Their Neonates, Archives of Gynecology and Obstetrics (2021)
20. Neurologic Manifestations of Covid-19, Advances in Experimental Medicine and Biology (2021)